Cargando…
Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls
OBJECTIVE: The present study was designed to compare the changes in ovarian and uterine parameters in girls with idiopathic central precocious puberty (ICPP) before and after gonadotropin-releasing hormone analogues (GnRHa) treatment to determine which sensitive indexes effectively reflect the thera...
Autores principales: | Yang, Kun, Qi, Rui-Fang, Li, Rong-Min, Zhang, Yu, Liu, Jing-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039020/ https://www.ncbi.nlm.nih.gov/pubmed/33854300 http://dx.doi.org/10.2147/DDDT.S298155 |
Ejemplares similares
-
Efficacy and Safety of Domestic Leuprorelin in Girls with Idiopathic Central Precocious Puberty: A Multicenter, Randomized, Parallel, Controlled Trial
por: Li, Wen-Jing, et al.
Publicado: (2015) -
The Diagnostic Value of Pelvic Ultrasound in Girls with Central Precocious Puberty
por: Lee, Sang Heon, et al.
Publicado: (2016) -
Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study
por: Yang, Jianmei, et al.
Publicado: (2022) -
Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty
por: Yu, Hong-kui, et al.
Publicado: (2019) -
Idiopathic central precocious puberty in girls: presentation factors
por: Prété, Géraldine, et al.
Publicado: (2008)